Agentix Corp. (AGTX) Stock
Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Agentix Corp.
Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
Agentix Corp. is headquartered in US.
Agentix Corp. (AGTX) stock trades at $0.02 with a market capitalization of $801339. The stock is valued at a price-to-earnings (P/E) ratio of -2.00, price-to-book of -0.22, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.01 and $0.06, and currently trades 66.7% below its 52-week high.
On profitability, Agentix Corp. generates a return on equity (ROE) of 14.09%, above the typical market average, return on capital employed of 12.38%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.agentixcorp.com